作者：
Julie,Vassart [1]
;
Marie,Didembourg [1]
;
Laure,Morimont [2]
;
Clotilde,Brisbois [3]
;
Laurent,Jamart [4]
;
Aurélien,Lebreton [5]
;
François,Mullier [6]
;
Nathalie,Donis [3]
;
Julien,Favresse [7]
;
Jean-Michel,Dogné [1]
;
Jonathan,Douxfils [8]
作者单位：
Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
[1]
Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium.
[2]
QUALIresearch, QUALIblood s.a., Namur, Belgium.
[3]
Service de cardiologie interventionnelle, Centre Hospitalier Régional Sambre et Meuse (CHRSM), Namur, Belgium.
[4]
Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.
[5]
Namur Thrombosis and Hemostasis Center (NTHC), CHU UCL NAMUR, Université catholique de Louvain, Belgium; Institut de Recherche Expérimentale et Clinique (IREC), Pôle Mont, Université catholique de Louvain, Yvoir, Belgium.
[6]
Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; Department of Clinical Biology, Clinique Saint-Luc Bouge (SLBO), Bouge, Belgium.
[7]
Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France. Electronic address: jonathan.douxfils@unamur.be.
[8]
DOI
10.1016/j.thromres.2024.109066
PMID
38897048
发布时间
2024-07-05
换一批
换一批
